低密度粒细胞与单核细胞作为系统性红斑狼疮心血管风险生物标志物
研究在109例SLE患者和33例对照中量化低密度粒细胞、单核细胞亚群、内皮祖细胞、血管生成T细胞等,并与亚临床颈动脉粥样硬化或心血管病关联;发现单核细胞与nLDG计数及MHR、nLHR在伴传统危险因素或亚临床粥样硬化的SLE患者中升高,且nLDG与cIMT正相关。第二队列31例新发SLE也显示其早期识别价值。
要点
- MHR和nLHR可作为SLE患者心血管病风险的潜在生物标志物,甚至诊断时即有价值。
- nLDGs与颈动脉内膜中层厚度及炎症标志物CRP、IL-6正相关。
- SLE患者中CD4+CD28null和Th17细胞增加并与cIMT相关,内皮祖细胞和Tang细胞减少。
核心结论
- MHR和nLHR可能是SLE患者心血管病风险的有价值生物标志物,甚至在诊断时即可应用。
- nLDGs、单核细胞、Th17和衰老CD28null亚群增加,伴促血管生成内皮祖细胞和Tang细胞减少,可能参与SLE动脉粥样硬化发生。
研究设计与样本
- 研究纳入109例SLE患者和33例对照,量化低密度粒细胞、单核细胞亚群、内皮祖细胞、血管生成T细胞、CD4+CD28null及Th1/Th17淋巴细胞和血清细胞因子,并与亚临床颈动脉粥样硬化或心血管病关联。
- 第二队列包括31例新发SLE患者。
主要发现
- 伴传统危险因素或亚临床粥样硬化的SLE患者单核细胞和LDG计数升高,尤其CD16/CD14阴性LDGs(nLDGs),以及单核细胞与HDLc比值(MHR)和nLDGs与HDLc比值(nLHR)升高,而无心血管病者未升高。
- nLDGs与颈动脉内膜中层厚度(cIMT)及炎症标志物(CRP和IL-6)正相关。
- 患者中观察到向更分化单核细胞亚群的偏移,与IFN-α和IL-17血清水平升高相关;中间型单核细胞尤其扩增,但独立于心血管病参与。
- CD4+CD28null、Th17和Th1淋巴细胞增加,其中CD4+CD28null和Th17细胞与cIMT相关;所有SLE患者内皮祖细胞和Tang细胞水平降低。
临床怎么用
- 可考虑将MHR和nLHR作为SLE患者心血管病风险评估的潜在生物标志物,包括诊断时。
- nLDGs、单核细胞、Th17和衰老CD28null亚群增加及内皮祖细胞和Tang细胞减少可能提示动脉粥样硬化发展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim was to evaluate the most relevant cell populations involved in vascular homeostasis as potential biomarkers of SLE-related cardiovascular disease (CVD). METHODS: Low-density granulocytes (LDGs), monocyte subsets, endothelial progenitor cells, angiogenic T (Tang) cells, CD4+CD28null and Th1/Th17 lymphocytes and serum cytokine levels were quantified in 109 SLE patients and 33 controls in relationship to the presence of subclinical carotid atheromatosis or cardiovascular disease. A second cohort including 31 recent-onset SLE patients was also included. RESULTS: Raised monocyte and LDG counts, particularly those LDGs negative for CD16/CD14 expression (nLDGs), in addition to the ratios of monocytes and nLDGs to high-density lipoprotein-cholesterol (HDLc) molecules (MHR and nLHR, respectively), were present in SLE patients with traditional risk factors or subclinical atheromatosis but not in those who were CV-free, thus revealing their value in the identification of patients at risk of CVD, even at the onset of disease. Accordingly, nLDGs were correlated positively with carotid intima-media thickness (cIMT) and with inflammatory markers (CRP and IL-6). A bias towards more differentiated monocyte subsets, related to increased IFN-α and IL-17 serum levels, was also observed in patients. Intermediate monocytes were especially expanded, but independently of their involvement in CVD. Finally, CD4+CD28null, Th17 and Th1 lymphocytes were increased, with CD4+CD28null and Th17 cells being associated with cIMT, whereas endothelial progenitor and Tang cell levels were reduced in all SLE patients. CONCLUSION: The present study highlights the potential use of MHR and nLHR as valuable biomarkers of CVD risk in SLE patients, even at diagnosis. The increased amounts of nLDGs, monocytes, Th17 and senescent-CD28null subsets, coupled with reduced pro-angiogenic endothelial progenitor cells and Tang cells, could underlie the development of atheromatosis in SLE.
引用
- López P, Rodríguez-Carrio J, Martínez-Zapico A, et al. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus. Rheumatology (Oxford). 2020. PMID: 32031658. doi:10.1093/rheumatology/keaa016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。